117 related articles for article (PubMed ID: 21923652)
21. Primary mediastinal large B-cell lymphoma with sclerosis in pediatric and adolescent patients: treatment and results from three therapeutic studies of the Berlin-Frankfurt-Münster Group.
Seidemann K; Tiemann M; Lauterbach I; Mann G; Simonitsch I; Stankewitz K; Schrappe M; Zimmermann M; Niemeyer C; Parwaresch R; Riehm H; Reiter A;
J Clin Oncol; 2003 May; 21(9):1782-9. PubMed ID: 12721255
[TBL] [Abstract][Full Text] [Related]
22. [Autologous stem-cell transplantations in children with non-Hodgkin lymphomas].
Wójcik B; Kowalczyk JR; Chybicka A; Wachowiak J; Drabko K; Zaucha-Prazmo A; Choma M; Gorczyńska E; Toporski J; Turkiewicz D; Kałwak K; Pieczonka A; Boruczkowski D
Przegl Lek; 2004; 61 Suppl 2():53-6. PubMed ID: 15686047
[TBL] [Abstract][Full Text] [Related]
23. [NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphomas in children and adolescents. Part 1: Classification and allocation to strategic therapy groups. BIF study group].
Reiter A; Tiemann M; Ludwig WD; Wacker HH; Yakisan E; Schrappe M; Henzler D; Sykora KW; Brandt A; Odenwald E
Klin Padiatr; 1994; 206(4):222-33. PubMed ID: 7967418
[TBL] [Abstract][Full Text] [Related]
24. Clinical course and therapeutic implications for lymphoid malignancies in Nijmegen breakage syndrome.
Pastorczak A; Szczepanski T; Mlynarski W;
Eur J Med Genet; 2016 Mar; 59(3):126-32. PubMed ID: 26826318
[TBL] [Abstract][Full Text] [Related]
25. Prognostic relevance of dic(9;20)(p11;q13) in childhood B-cell precursor acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Münster (BFM) protocols containing an intensive induction and post-induction consolidation therapy.
Pichler H; Möricke A; Mann G; Teigler-Schlegel A; Niggli F; Nebral K; König M; Inthal A; Krehan D; Dworzak MN; Janousek D; Harbott J; Schrappe M; Gadner H; Strehl S; Haas OA; Panzer-Grümayer R; Attarbaschi A;
Br J Haematol; 2010 Apr; 149(1):93-100. PubMed ID: 20067563
[TBL] [Abstract][Full Text] [Related]
26. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
Salzburg J; Burkhardt B; Zimmermann M; Wachowski O; Woessmann W; Oschlies I; Klapper W; Wacker HH; Ludwig WD; Niggli F; Mann G; Gadner H; Riehm H; Schrappe M; Reiter A
J Clin Oncol; 2007 Sep; 25(25):3915-22. PubMed ID: 17761975
[TBL] [Abstract][Full Text] [Related]
27. [NHL-BFM 90 therapy study in treatment of malignant non-Hodgkin's lymphoma in children and adolescents. Part 3: An intermediate term analysis of the B-NHL/B-ALL].
Reiter A; Schrappe M; Yakisan E; Sauter S; Ebell W; Zimmermann M; Hartmann W; Kremens B; Kuhn N; Claviez A
Klin Padiatr; 1994; 206(4):242-52. PubMed ID: 7967420
[TBL] [Abstract][Full Text] [Related]
28. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
29. Treatment of children and young adults with early-stage non-Hodgkin's lymphoma.
Link MP; Shuster JJ; Donaldson SS; Berard CW; Murphy SB
N Engl J Med; 1997 Oct; 337(18):1259-66. PubMed ID: 9345074
[TBL] [Abstract][Full Text] [Related]
30. Immunodeficiency and Hodgkin's disease: treatment and outcome in the DAL HD78-90 and GPOH HD95 studies.
Niehues T; Schellong G; Dörffel W; Bucsky P; Mann G; Körholz D; Göbel U
Klin Padiatr; 2003; 215(6):315-20. PubMed ID: 14677095
[TBL] [Abstract][Full Text] [Related]
31. Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center.
Mora J; Filippa DA; Qin J; Wollner N
Cancer; 2003 Sep; 98(6):1283-91. PubMed ID: 12973853
[TBL] [Abstract][Full Text] [Related]
32. Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma.
Burkhardt B; Woessmann W; Zimmermann M; Kontny U; Vormoor J; Doerffel W; Mann G; Henze G; Niggli F; Ludwig WD; Janssen D; Riehm H; Schrappe M; Reiter A
J Clin Oncol; 2006 Jan; 24(3):491-9. PubMed ID: 16421426
[TBL] [Abstract][Full Text] [Related]
33. Impaired renal function and tumor lysis syndrome in pediatric patients with non-Hodgkin's lymphoma and B-ALL. Observations from the BFM-trials.
Seidemann K; Meyer U; Jansen P; Yakisan E; Rieske K; Führer M; Kremens B; Schrappe M; Reiter A
Klin Padiatr; 1998; 210(4):279-84. PubMed ID: 9743966
[TBL] [Abstract][Full Text] [Related]
34. Nijmegen breakage syndrome (NBS) as a risk factor for CNS involvement in childhood acute lymphoblastic leukemia.
Pastorczak A; Stolarska M; Trelińska J; Zawitkowska J; Kowalczyk J; Mlynarski W;
Pediatr Blood Cancer; 2011 Jul; 57(1):160-2. PubMed ID: 21557461
[TBL] [Abstract][Full Text] [Related]
35. Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: results from ALL-BFM 90 and 95.
Schrauder A; Reiter A; Gadner H; Niethammer D; Klingebiel T; Kremens B; Peters C; Ebell W; Zimmermann M; Niggli F; Ludwig WD; Riehm H; Welte K; Schrappe M
J Clin Oncol; 2006 Dec; 24(36):5742-9. PubMed ID: 17179108
[TBL] [Abstract][Full Text] [Related]
36. Clinical characteristics and treatment results of pediatric B-cell non-Hodgkin lymphoma patients in a single center.
Karadeniz C; Oguz A; Citak EC; Uluoglu O; Okur V; Demirci S; Okur A; Aksakal N
Pediatr Hematol Oncol; 2007 Sep; 24(6):417-30. PubMed ID: 17710659
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
[TBL] [Abstract][Full Text] [Related]
38. Therapy for non-Hodgkin lymphoma in children with primary immunodeficiency: analysis of 19 patients from the BFM trials.
Seidemann K; Tiemann M; Henze G; Sauerbrey A; Müller S; Reiter A
Med Pediatr Oncol; 1999 Dec; 33(6):536-44. PubMed ID: 10573576
[TBL] [Abstract][Full Text] [Related]
39. [Efficacy of short-term and intensive chemotherapy for the treatment of childhood and adolescent B cell non-Hodgkin's lymphoma].
Sun XF; Liu DG; Zhen ZJ; Chen XQ; Xia Y; Wang ZH; He YJ; Guan ZG
Zhonghua Xue Ye Xue Za Zhi; 2005 Oct; 26(10):581-4. PubMed ID: 16532964
[TBL] [Abstract][Full Text] [Related]
40. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
